BIOL
Biolase, Inc.
BIOL
BIOL
Delisted
BIOL was delisted on the 18th of June, 2024.
19 hedge funds and large institutions have $448K invested in Biolase, Inc. in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$60.7K | |
| 2 | +$43.6K | |
| 3 | +$35K | |
| 4 |
VF
Virtu Financial
New York
|
+$34.4K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$16K |
Top Sellers
| 1 | -$1.7M | |
| 2 | -$152K | |
| 3 | -$124K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$43K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$19.7K |